Stocks
Merck Q4 2025 Earnings: Keytruda Powers Beat But 2026 Outlook Disappoints
Merck just posted solid Q4 numbers thanks to its cancer star Keytruda, but the 2026 forecast came in softer than...
03/02/2026
2 views